Skip to main content

Table 1 Fraction of cancers attributable to all HPV types and to 9-valent HPV vaccine typesa by cancer site

From: Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe

Cancer site

ICD-10 code

Fraction attributable to all HPV types

% [95% CI]b

Fraction attributable to 4-valent HPV vaccine types (6/11/16/18) % [95% CI]b

Fraction attributable to 9-valent HPV vaccine types (6/11/16/18/31/33/45/52/58)

% [95% CI]b

Reference

Cervix

C53

100c

72.9 [71.0-74.8]

89.1 [87.7-90.4]

[13]

Vulva

C51

15.9 [13.5-18.4]

84.4 [77.3-90.0]

94.3 [89.1-97.5]

[14]

Vagina

C52

70.2 [62.2-77.4]

72.6 [63.1-80.9]

87.1 [78.8-92.6]

[16]

Anus

C21

87.1 [81.0-91.8]

91.5 [85.7-95.6]

94.4 [89.2-97.5]

[15]

Penis

C60

29.0 [24.7-33.7]

78.9 [70.6-85.9]

90.7 [84.1-95.3]

[7]

Oral cavity

C02-06

3.7 [2.4-5.6]

90.9 [70.8-98.9]

90.9 [70.8-98.9]

[6]

Nasopharynx

C11

10.8 [3.0-25.4]

75.0 [19.4-99.4]

75.0 [19.4-99.4]

[6]

Oropharynx

C01, C09, C10

19.9 [17.2-22.8]

93.8 [88.8-97.0]

97.5 [93.7-99.3]

[6]

Hypopharynx

C12-13

2.4 [0.3-8.4]

50.0 [1.3-98.7]

100 [15.8-100]

[6]

Pharynx

C14

25.0 [10.7-44.9]

85.7 [42.1-99.6]

85.7 [42.1-99.6]

[6]

Larynx

C32

2.4 [1.2-4.1]

66.7 [34.9-90.1]

91.7 [61.5-99.8]

[6]

  1. CI confidence interval, HPV human papillomavirus, ICD-10 International Classification of Diseases, 10th Revision, CI confidence interval
  2. aAdjusted for multiple infections; bExcept for cervical cancer, prevalence is based on oncogenically-active HPV infections only (i.e., HPV DNA detection plus either E6*I mRNA expression or p16 overexpression). cHPV is the necessary cause for cervical cancer [12]